Literature DB >> 23184330

Gray matter atrophy in Parkinson's disease with dementia: evidence from meta-analysis of voxel-based morphometry studies.

Ping Lei Pan1, Hai Cun Shi, Jian Guo Zhong, Pei Rong Xiao, Yuan Shen, Li Juan Wu, Yuan Ying Song, Gui Xiang He, Hua Liang Li.   

Abstract

Voxel-based morphometry (VBM) studies have provided cumulative evidence of gray matter (GM) atrophy in patients with Parkinson's disease with dementia (PDD) relative to healthy controls (HC). However, not all the studies reported entirely consistent findings. A systematic search for VBM studies of PDD patients and HC subjects published in PubMed and Embase databases from January 2000 to June 2012 was conducted. Meta-analysis was performed by using a newly improved voxel-based meta-analytic technique, effect size signed differential mapping, to quantitatively explore the GM abnormalities between PDD patients and HC subjects. A total of 6 cross-sectional VBM studies involving 105 PDD patients and 131 HC subjects met the inclusion criteria. Considerable regional GM decrease was detected in the medial temporal lobe (MTL) and basal ganglia. The findings of the present study remained largely unchanged in the entire brain jackknife sensitivity analyses. Meta-regression showed dementia severity correlated with the left MTL. The present meta-analysis provided evidence of PDD-related GM atrophy, which suggested MTL and basal ganglia were implicated in PDD. This finding could give us further insight about the pathophysiological basis revealed by structure abnormalities in PDD.

Entities:  

Mesh:

Year:  2012        PMID: 23184330     DOI: 10.1007/s10072-012-1250-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  51 in total

Review 1.  The primate basal ganglia: parallel and integrative networks.

Authors:  Suzanne N Haber
Journal:  J Chem Neuroanat       Date:  2003-12       Impact factor: 3.052

2.  Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.

Authors:  M L Kraybill; E B Larson; D W Tsuang; L Teri; W C McCormick; J D Bowen; W A Kukull; J B Leverenz; M M Cherrier
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

3.  Grey matter atrophy in cognitively impaired Parkinson's disease.

Authors:  Tracy R Melzer; Richard Watts; Michael R MacAskill; Toni L Pitcher; Leslie Livingston; Ross J Keenan; John C Dalrymple-Alford; Tim J Anderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-09-02       Impact factor: 10.154

4.  Dementia with Lewy bodies and Parkinson's disease dementia may best be viewed as two distinct entities.

Authors:  Gonzalo J Revuelta; Carol F Lippa
Journal:  Int Psychogeriatr       Date:  2009-01-28       Impact factor: 3.878

5.  A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel-based morphometry.

Authors:  Ji E Lee; Bosuk Park; Sook K Song; Young H Sohn; Hae-Jeong Park; Phil Hyu Lee
Journal:  Mov Disord       Date:  2010-01-15       Impact factor: 10.338

6.  Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia.

Authors:  Naroa Ibarretxe-Bilbao; Blanca Ramírez-Ruiz; Eduardo Tolosa; María Jose Martí; Francesc Valldeoriola; Nuria Bargalló; Carme Junqué
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

7.  Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.

Authors:  Mona K Beyer; Jan P Larsen; Dag Aarsland
Journal:  Neurology       Date:  2007-08-21       Impact factor: 9.910

8.  Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease.

Authors:  P M Mattila; M Röyttä; H Torikka; D W Dickson; J O Rinne
Journal:  Acta Neuropathol       Date:  1998-06       Impact factor: 17.088

9.  Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease.

Authors:  Thomas P Bouchard; Nikolai Malykhin; W R Wayne Martin; Christopher C Hanstock; Derek J Emery; Nancy J Fisher; Richard M Camicioli
Journal:  Neurobiol Aging       Date:  2007-03-26       Impact factor: 4.673

10.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

Authors:  Emma J Burton; Ian G McKeith; David J Burn; E David Williams; John T O'Brien
Journal:  Brain       Date:  2004-01-28       Impact factor: 13.501

View more
  24 in total

1.  Gray matter atrophy in patients with Parkinson's disease and those with mild cognitive impairment: a voxel-based morphometry study.

Authors:  Jing Zhang; Yun-Ting Zhang; Wei-Dong Hu; Li Li; Guang-Yao Liu; Yu-Ping Bai
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  A meta-analysis of voxel-based morphometric studies on migraine.

Authors:  Wenting Hu; Jian Guo; Ning Chen; Jiang Guo; Li He
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 3.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

4.  Longitudinal Study of Gray Matter Changes in Parkinson Disease.

Authors:  X Jia; P Liang; Y Li; L Shi; D Wang; K Li
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-10       Impact factor: 3.825

5.  Subcortical atrophy is associated with cognitive impairment in mild Parkinson disease: a combined investigation of volumetric changes, cortical thickness, and vertex-based shape analysis.

Authors:  E Mak; N Bergsland; M G Dwyer; R Zivadinov; N Kandiah
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-31       Impact factor: 3.825

6.  Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease.

Authors:  Yaqian Xu; Jing Yang; Xinyu Hu; Huifang Shang
Journal:  J Neurol       Date:  2016-04-25       Impact factor: 4.849

7.  White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease.

Authors:  Ian O Bledsoe; Glenn T Stebbins; Doug Merkitch; Jennifer G Goldman
Journal:  Neurology       Date:  2018-11-14       Impact factor: 9.910

8.  Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease.

Authors:  Jennifer G Goldman; Ian O Bledsoe; Doug Merkitch; Vy Dinh; Bryan Bernard; Glenn T Stebbins
Journal:  Neurology       Date:  2017-02-24       Impact factor: 9.910

9.  Central nervous system (CNS) transcriptomic correlates of human immunodeficiency virus (HIV) brain RNA load in HIV-infected individuals.

Authors:  Pietro Paolo Sanna; Yu Fu; Eliezer Masliah; Celine Lefebvre; Vez Repunte-Canonigo
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.996

10.  Association of regional cerebral perfusion impairment with gait and balance performance in dizzy patients using brain perfusion SPECT: Voxel-based analysis of a pilot sample.

Authors:  Reza Nemati; Mohamad Ali Nayeri; Negar Chabi; Zahra Akbari; Esmail Jafari; Hossein Shooli; Habibollah Dadgar; Majid Assadi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.